Business Context and Reporting Period
This Form 8-K was filed by OrthoPediatrics Corp. on November 1, 2022. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol KIDS. The filing serves as a Regulation FD disclosure regarding upcoming investor and analyst presentations.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the use of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements within the body of the report.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document solely announces the intent of executive officers to utilize the attached investor presentation for upcoming communications.
Guidance, Outlook, and Risks
- Management Commentary: Executive officers plan to use the material in Exhibit 99.1 for investor presentations.
- Legal Status of Information: The information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
- Emerging Growth Company: The registrant has indicated it is an emerging growth company.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Orthopediatrics Corp. Investor Presentation dated November 2022) for actual financial data, guidance, and strategic outlook, as this 8-K only references the document.
- Verify the company's status as an emerging growth company and any associated election regarding extended transition periods for accounting standards.
- Note that the information in this filing is not incorporated by reference into other SEC filings unless specifically cited.